Atlas Trials

Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

Clinical trial NCT00972881 · COMPLETED

Trial details

NCT number
NCT00972881
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2009-04-01
Primary completion
2011-12-01
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.